Distance to first symptoms measured by the 6-min walking test differentiates between treatment success and failure in patients with degenerative lumbar disorders.

Publication

Distance to first symptoms measured by the 6-min walking test differentiates between treatment success and failure in patients with degenerative lumbar disorders.

Journal Paper/Review - Jan 11, 2022

Zeitlberger Anna M, Sosnova Marketa, Ziga Michal, Gautschi Oliver P, Regli Luca, Bozinov Oliver, Weyerbrock Astrid, Stienen Martin N, Maldaner Nicolai

Citation

Zeitlberger A, Sosnova M, Ziga M, Gautschi O, Regli L, Bozinov O, Weyerbrock A, Stienen M, Maldaner N. Distance to first symptoms measured by the 6-min walking test differentiates between treatment success and failure in patients with degenerative lumbar disorders. Eur Spine J 2022; 31:596-603.

Type

Journal Paper/Review (English)

Journal

Eur Spine J 2022; 31

Publication Date

Jan 11, 2022

Issn Electronic

1432-0932

Pages

596-603

Brief description/objective

The smartphone-based 6-min walking test (6WT) is an established digital outcome measure in patients undergoing surgery for degenerative lumbar disorders (DLD). In addition to the 6WTs primary outcome measure, the 6-min walking distance (6WD), the patient's distance to first symptoms (DTFS) and time to first symptoms (TTFS) can be recorded. This is the first study to analyse the psychometric properties of the DTFS and TTFS.